Researchers explore the association of respiratory illness based on self-reported symptoms among young adolescents who vaped.
Signal: LimmaTech raises $37m for antimicrobial resistance research – Pharmaceutical Technology
Franz-Werner Haas, LimmaTech CEO. Photo: Thomas Kienzle/AFP via Getty Images. Limmatech, the GSK spinout focusing on antimicrobial resistance, announced on Monday (9 October) that it